The impact of BMI on response to controlled ovarian hyperstimulation in in vitro fertilization/intracytoplasmic sperm injection cycles, aretrospective cohort study.
Main Author: | Berglund, Charlotte |
---|---|
Format: | Others |
Language: | English |
Published: |
Örebro universitet, Institutionen för läkarutbildning
2015
|
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-45986 |
Similar Items
-
Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoingin vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study
by: Niyazi Kilic, et al.
Published: (2015-10-01) -
Comparison of aneuploidy rates between conventional in vitro fertilization and intracytoplasmic sperm injection in in vitro fertilization–intracytoplasmic sperm injection split insemination cycles
by: Jie Deng, M.D., Ph.D., et al.
Published: (2020-12-01) -
Maternal and Neonatal Complications in Patients With Diminished Ovarian Reserve in In-Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles
by: Shuang Han, et al.
Published: (2021-04-01) -
Comparison of Cabergoline and Quinagolide in Prevention of Severe Ovarian Hyperstimulation Syndrome among Patients Undergoing Intracytoplasmic Sperm Injection
by: Robabeh Taheripanah, et al.
Published: (2018-04-01) -
In vitro fertilization/intracytoplasmic sperm injection for male infertility
by: Rubina Merchant, et al.
Published: (2011-01-01)